Fortress Biotech, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Fair Value Measurements (Tables)

Fair Value Measurements (Tables)

6 Months Ended

Jun. 30, 2023

Warrants to Purchase Common Stock [Member]

Schedule of revaluation of warrant liability


		Warrants
($ in thousands)		liabilities
Balance at December 31, 2022		$	13,869
Avenue common stock warrants			2,235
Urica placement agent warrants			33
Change in fair value of common stock warrants - Avenue			1,028
Change in fair value of common stock warrants - Checkpoint			(7,209)
Change in fair value of common stock warrants - Urica			15
Balance as of June 30, 2023		$	9,971

Warrants to Purchase Common Stock [Member] | Checkpoint Common Stock Warrants

Schedule of revaluation of warrant liability


		Checkpoint
		Warrant
($ in thousands)		Liability
Common Stock Warrant liabilities at December 31, 2022		$	11,170
Change in fair value of common stock warrant liabilities			(7,209)
Common Stock Warrant liabilities at June 30, 2023		$	3,961

Warrants to Purchase Common Stock [Member] | Avenue Therapeutics, Inc [Member]

Schedule of revaluation of warrant liability


		Avenue
		Warrant
($ in thousands)		Liability
Common Stock Warrant liabilities at December 31, 2022		$	2,609
Issuance of Avenue common warrants			2,235
Change in fair value of common stock warrant liabilities			1,028
Common Stock Warrant liabilities at June 30, 2023		$	5,872

Summary of the Weighted average Significant Unobservable Inputs


		June 30,			January 31			December 31
		2023			2023			2022
Stock price	$	1.17		$	1.16		$	1.16
Risk-free interest rate		3.6 - 3.8	%		3.90	%		4.02	%
Expected dividend yield		—			—			—
Expected term in years		2.8 - 4.5			3.00			4.78
Expected volatility		137 - 164	%		160	%		93	%

Warrants to Purchase Common Stock [Member] | Urica

Summary of the Weighted average Significant Unobservable Inputs


		June 30,			December 31
		2023			2022
Risk-free interest rate		5.40	%		3.94	%
Expected dividend yield		—			—
Expected term in years		1.0			1.5
Expected volatility		86.5	%		70.7	%

Series A Warrants | Checkpoint Common Stock Warrants

Summary of the Weighted average Significant Unobservable Inputs


		June 30,				December 31,
Checkpoint Warrants		2023				2022
Exercise price		$	4.08 - 5.41			$	4.08 - 5.41
Volatility			90.7 - 108.2	%			82.4 - 89.4	%
Expected life			1.0 - 4.5				1.5 - 5.0
Risk-free rate			4.1 - 5.4	%			4.0 - 4.7	%
Dividend yield			—				—